An existing research unveiled that FOXP2 was downregulated in hyperglycemia and it enhances the cell viability, proliferation, and migration of high glucose (HG)-induced human microvascular endothelial cells, thereby attenuating and relieving diabetes symptoms [18,19]. Here, FOXP2 is linked to diabetes mellitus.